These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8087124)

  • 1. Neuroendocrine cells and airway wall remodelling in chronic airflow obstruction: a perspective.
    Aguayo SM
    Monaldi Arch Chest Dis; 1994 Jun; 49(3):243-8. PubMed ID: 8087124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of susceptibility to cigarette smoke. Potential roles for neuroendocrine cells and neuropeptides in airway inflammation, airway wall remodeling, and chronic airflow obstruction.
    Aguayo SM
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1692-8. PubMed ID: 7911710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease.
    Saetta M; Di Stefano A; Turato G; Facchini FM; Corbino L; Mapp CE; Maestrelli P; Ciaccia A; Fabbri LM
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):822-6. PubMed ID: 9517597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of neuroendocrine cells and bombesin neuropeptides in the pathogenesis of smoking related diseases, especially chronic obstructive pulmonary disease].
    Siemińska A; Olszewska A
    Pneumonol Alergol Pol; 1997; 65(1-2):123-8. PubMed ID: 9289294
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased serum levels of chromogranin A in male smokers with airway obstruction.
    Sørhaug S; Langhammer A; Waldum HL; Hveem K; Steinshamn S
    Eur Respir J; 2006 Sep; 28(3):542-8. PubMed ID: 16707514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease.
    Maestrelli P; Saetta M; Mapp CE; Fabbri LM
    Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 2):S76-80. PubMed ID: 11734472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased pulmonary neuroendocrine cells with bombesin-like immunoreactivity in adult patients with eosinophilic granuloma.
    Aguayo SM; King TE; Waldron JA; Sherritt KM; Kane MA; Miller YE
    J Clin Invest; 1990 Sep; 86(3):838-44. PubMed ID: 2394833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary neuroendocrine cells in tobacco-related lung disorders.
    Aguayo SM
    Anat Rec; 1993 May; 236(1):122-7; discussion 127-8. PubMed ID: 8506997
    [No Abstract]   [Full Text] [Related]  

  • 9. Bombesin-like peptides and mast cell responses: relevance to bronchopulmonary dysplasia?
    Subramaniam M; Sugiyama K; Coy DH; Kong Y; Miller YE; Weller PF; Wada K; Wada E; Sunday ME
    Am J Respir Crit Care Med; 2003 Sep; 168(5):601-11. PubMed ID: 12807697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphologic determinants of airway responsiveness in chronic smokers.
    Riess A; Wiggs B; Verburgt L; Wright JL; Hogg JC; Paré PD
    Am J Respir Crit Care Med; 1996 Nov; 154(5):1444-9. PubMed ID: 8912762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cartilaginous airway dimensions and airflow obstruction in human lungs.
    Tiddens HA; Paré PD; Hogg JC; Hop WC; Lambert R; de Jongste JC
    Am J Respir Crit Care Med; 1995 Jul; 152(1):260-6. PubMed ID: 7599833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Roles of airway inflammation in chronic airflow obstruction].
    Koga T; Oizumi K
    Nihon Rinsho; 1999 Sep; 57(9):1995-8. PubMed ID: 10497396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early discrimination between intrinsic and extrinsic factors in chronic obstructive lung disease.
    Vezzoli F; Soroldoni M; Longhini E
    Respiration; 1977; 34(5):256-69. PubMed ID: 905664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airway disease in a subset of nonsmoking rheumatoid patients. Characterization of the disease and evidence for an autoimmune pathogenesis.
    Bégin R; Massé S; Cantin A; Ménard HA; Bureau MA
    Am J Med; 1982 May; 72(5):743-50. PubMed ID: 6979249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic airflow obstruction. Evolution of disordered function in cigarette smokers.
    Colebatch HJ; Greaves IA
    Med J Aust; 1985 May; 142(11):607-10. PubMed ID: 4000025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathology of chronic airflow obstruction.
    Thurlbeck WM
    Chest; 1990 Feb; 97(2 Suppl):6S-10S. PubMed ID: 2404712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group.
    Tashkin DP; Altose MD; Connett JE; Kanner RE; Lee WW; Wise RA
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1802-11. PubMed ID: 8665038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic obstructive pulmonary disease: less common causes--an algorithm for the primary care physician.
    St John RC; Gadek JE; Pacht ER
    J Gen Intern Med; 1993 Oct; 8(10):564-72. PubMed ID: 8271090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise Tolerance according to the Definition of Airflow Obstruction in Smokers.
    Neder JA; Milne KM; Berton DC; de-Torres JP; Jensen D; Tan WC; Bourbeau J; O'Donnell DE;
    Am J Respir Crit Care Med; 2020 Sep; 202(5):760-762. PubMed ID: 32343595
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of airflow obstruction in smokers and never-smokers in Switzerland.
    Bridevaux PO; Probst-Hensch NM; Schindler C; Curjuric I; Felber Dietrich D; Braendli O; Brutsche M; Burdet L; Frey M; Gerbase MW; Ackermann-Liebrich U; Pons M; Tschopp JM; Rochat T; Russi EW
    Eur Respir J; 2010 Dec; 36(6):1259-69. PubMed ID: 20413537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.